ABCL

Q: What is the price of AbCellera Biologics (ABCL) today?

The price of AbCellera Biologics (ABCL) today is $ 3.42, with return of 16.72% compared to the last year. The price of AbCellera Biologics (ABCL) started the year trading around $ 3.42 and today it is at $ 3.42. Follow the real-time price chart, the historical price of AbCellera Biologics (ABCL) and international markets.

Q: When does AbCellera Biologics (ABCL) pay dividends?

AbCellera Biologics (ABCL) did not distribute dividends in the last year.

Q: Is AbCellera Biologics (ABCL) worth it?

Currently, AbCellera Biologics (ABCL) is priced at $ 3.42, with a P/E of -6.23%, representing a deviation of -114% from its historical average P/E. In the last year, the stock showed a variation of 16.72 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 16.72%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy AbCellera Biologics (ABCL) stock?

Investing in stocks of AbCellera Biologics (ABCL) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of AbCellera Biologics (ABCL) yield today?

The yield of AbCellera Biologics (ABCL) was -1.16% in the last month, 16.72% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of AbCellera Biologics (ABCL) today, the total investment would be $ 342.00, based on the current price of $ 3.42.If past performance were to repeat, the return on your investment would be:In 1 year: $ 399.18In 5 years: $ 342.00In 10 years: $ 342.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AbCellera Biologics Inc.

Price

$ 3.42

return (12m)

16.72%

p/e

-6.23

p/bv

1.11

DIVIDEND YIELD

0.00%

price ABCL

ABCL

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of ABCL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-1.16%

3 months

-42.03%

1 year

16.72%

2 years

-40.31%

5 years

0.00%

10 years

0.00%

Fundamentals ABCL

review the fundamentals of AbCellera Biologics shares

P/E

-6.23

Sector: -2.27 Industry: -5.13

P/SALES RATIO (PSR)

30.30

Sector: 2.11 Industry: 3.29

P/BV

1.11

Sector: 2.29 Industry: 2.34

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-12.66%

Sector: -27.12% Industry: -53.24%

ROE

-17.81%

Sector: -30.07% Industry: -44.16%

ROIC

-29.92%

Sector: -415.70% Industry: -476.08%

NET MARGIN

-100.00%

Sector: -28.13% Industry: -33.39%

GROSS MARGIN

100.00%

Sector: 44.12% Industry: 45.08%

OPERATING MARGIN

-100.00%

Sector: -24.27% Industry: -29.79%

P/EBITDA

-5.04

Sector: -0.31 Industry: -3.82

P/EBIT

-4.33

Sector: -2.62 Industry: -5.50

P/ASSET

0.79

Sector: 1.24 Industry: 1.50

BVPS

3.22

Sector: 3.36 Industry: 1.64

EPS

-0.57

Sector: -0.89 Industry: -1.28

EQUITY RATIO

0.71

Sector: 0.43 Industry: 0.46

CAGR REVENUE 5 YEARS

-31.62%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals ABCL

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	52.51	40.53	77.20%	0.56%	$ 966.74 B	30.99%
ISRG	75.09	12.10	16.12%	0.00%	$ 206.28 B	28.58%
TMO	33.41	4.29	12.84%	0.29%	$ 219.52 B	15.02%
SNY	10.54	1.47	13.90%	4.56%	$ 118.80 B	14.83%
MDT	25.97	0.00	0.00%	2.92%	$ 123.74 B	13.71%
NVS	18.62	5.99	32.16%	2.78%	$ 268.06 B	25.53%
ABT	15.54	4.24	27.26%	1.89%	$ 217.16 B	31.88%
CVS	215.41	1.38	0.64%	3.34%	$ 101.03 B	0.12%
GSK	13.56	4.65	34.29%	3.36%	$ 99.00 B	17.23%
BSX	50.99	0.00	0.00%	0.00%	$ 142.36 B	14.43%
TMDX	46.02	11.89	25.84%	0.00%	$ 4.22 B	16.20%
HCA	17.52	-51.49	-293.84%	0.60%	$ 111.17 B	8.53%
IDXX	53.61	35.28	65.81%	0.00%	$ 55.08 B	24.65%
DHR	46.75	3.21	6.86%	0.53%	$ 163.76 B	14.43%
INMD	6.16	1.41	22.89%	0.00%	$ 921.06 M	41.04%
RMD	24.85	5.84	23.49%	0.92%	$ 35.73 B	27.35%
FMS	17.26	0.86	5.00%	3.26%	$ 14.08 B	3.73%
SYK	45.98	6.21	13.51%	0.95%	$ 135.31 B	12.07%
PHG	114.48	2.08	1.81%	3.27%	$ 25.78 B	1.14%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ABCL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY AbCellera Biologics

AbCellera Biologics Inc.

Average user rating I10

4.0 (4 people)

United States

14 years

Founded: 2012

2020

Time since IPO - 6 years

206

Employees

The Company AbCellera Biologics Inc. (United States), is listed on Nasdaq with a market value of $ 1.07 Billion, having an equity of $ 964.04 Millions.

With a total of 206 employees, the company is listed in the sector of Health and categorized in industry of Life Science Tools and Services.

In the last 12 months the Company had a revenue of $ 35.33 Millions, which generated a loss in the amount of $ -171.68 Millions.

As for its main indicators, the Company has a P/E ratio of -6.23, a P/BV ratio of 1.11 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ABCL.

Market cap

$ 1.07 Billion

Net worth

$ 964.04 Millions

US$ 964,040,000.00

Assets

$ 1.36 Billion

US$ 1,355,990,000.00

Total Shares Outstanding

299.00 Millions

299,000,000

Average Daily Trading Volume

$ 4.15 Millions

US$ 4,154,379.86

Sector

Health

Industry

Life Science Tools and Services

ABCL

ABCL revenue and profits

Financial Results ABCL

DRAG THE FRAME TO SEE MORE DATA

ABCL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.36 87,14% (12M)

P/E

215.41

3.34%

ROE

0.64%

P/BV

1.38

CI - Cigna

$ 275.23 2,33% (12M)

P/E

11.97

2.18%

ROE

14.63%

P/BV

1.75

CNC - Centene

$ 41.15 --31,99% (12M)

P/E

-3.76

0.00%

ROE

-25.12%

P/BV

0.94

HUM - Humana

$ 256.13 3,15% (12M)

P/E

24.06

1.37%

ROE

6.95%

P/BV

1.67

SNY - Sanofi

$ 48.46 5,02% (12M)

P/E

10.54

4.56%

ROE

13.90%

P/BV

1.47

HCA - HCA Healthcare

$ 466.86 58,55% (12M)

P/E

17.52

0.60%

ROE

-293.84%

P/BV

-51.49

LLY - Eli Lilly

$ 1,074.68 38,67% (12M)

P/E

52.51

0.56%

ROE

77.20%

P/BV

40.53